294 related articles for article (PubMed ID: 27300699)
1. Prenatal Exposure to Histone Deacetylase Inhibitors Affects Gene Expression of Autism-Related Molecules and Delays Neuronal Maturation.
Kawanai T; Ago Y; Watanabe R; Inoue A; Taruta A; Onaka Y; Hasebe S; Hashimoto H; Matsuda T; Takuma K
Neurochem Res; 2016 Oct; 41(10):2574-2584. PubMed ID: 27300699
[TBL] [Abstract][Full Text] [Related]
2. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid.
Kataoka S; Takuma K; Hara Y; Maeda Y; Ago Y; Matsuda T
Int J Neuropsychopharmacol; 2013 Feb; 16(1):91-103. PubMed ID: 22093185
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain.
Foti SB; Chou A; Moll AD; Roskams AJ
Int J Dev Neurosci; 2013 Oct; 31(6):434-47. PubMed ID: 23542004
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice.
Moldrich RX; Leanage G; She D; Dolan-Evans E; Nelson M; Reza N; Reutens DC
Behav Brain Res; 2013 Nov; 257():253-64. PubMed ID: 24103642
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.
Takuma K; Hara Y; Kataoka S; Kawanai T; Maeda Y; Watanabe R; Takano E; Hayata-Takano A; Hashimoto H; Ago Y; Matsuda T
Pharmacol Biochem Behav; 2014 Nov; 126():43-9. PubMed ID: 25240644
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
Menegola E; Di Renzo F; Broccia ML; Prudenziati M; Minucci S; Massa V; Giavini E
Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):392-8. PubMed ID: 16193500
[TBL] [Abstract][Full Text] [Related]
7. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells.
Luo Z; Wang Z; He X; Liu N; Liu B; Sun L; Wang J; Ma F; Duncan H; He W; Cooper P
Int Endod J; 2018 Jul; 51(7):767-778. PubMed ID: 28375564
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
Jeong SG; Ohn T; Kim SH; Cho GW
Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brain.
Hara Y; Ago Y; Takano E; Hasebe S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Mol Autism; 2017; 8():33. PubMed ID: 28670439
[TBL] [Abstract][Full Text] [Related]
11. Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring.
Kim KC; Lee DK; Go HS; Kim P; Choi CS; Kim JW; Jeon SJ; Song MR; Shin CY
Mol Neurobiol; 2014 Feb; 49(1):512-28. PubMed ID: 24030726
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons.
Marinova Z; Leng Y; Leeds P; Chuang DM
Neuropharmacology; 2011 Jun; 60(7-8):1109-15. PubMed ID: 20888352
[TBL] [Abstract][Full Text] [Related]
13. Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2.
Chandwani S; Keilani S; Ortiz-Virumbrales M; Morant A; Bezdecny S; Ehrlich ME
PLoS One; 2013; 8(10):e76842. PubMed ID: 24204683
[TBL] [Abstract][Full Text] [Related]
14. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
Leng Y; Chuang DM
J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
[TBL] [Abstract][Full Text] [Related]
15. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells.
Vukićević V; Qin N; Balyura M; Eisenhofer G; Wong ML; Licinio J; Bornstein SR; Ehrhart-Bornstein M
Mol Psychiatry; 2015 Aug; 20(8):941-50. PubMed ID: 25707399
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice.
Kolozsi E; Mackenzie RN; Roullet FI; deCatanzaro D; Foster JA
Neuroscience; 2009 Nov; 163(4):1201-10. PubMed ID: 19607885
[TBL] [Abstract][Full Text] [Related]
18. Exposure to valproic acid inhibits chondrogenesis and osteogenesis in mid-organogenesis mouse limbs.
Paradis FH; Hales BF
Toxicol Sci; 2013 Jan; 131(1):234-41. PubMed ID: 23042728
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder.
Kuo HY; Liu FC
FASEB J; 2017 Oct; 31(10):4458-4471. PubMed ID: 28687613
[TBL] [Abstract][Full Text] [Related]
20. Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model.
Hara Y; Takuma K; Takano E; Katashiba K; Taruta A; Higashino K; Hashimoto H; Ago Y; Matsuda T
Behav Brain Res; 2015 Aug; 289():39-47. PubMed ID: 25907743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
